{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T20:35:58Z","timestamp":1771014958501,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Lymphoma and Myeloma"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.3816\/clm.2008.n.020","type":"journal-article","created":{"date-parts":[[2008,9,11]],"date-time":"2008-09-11T01:11:08Z","timestamp":1221095468000},"page":"166-170","source":"Crossref","is-referenced-by-count":22,"title":["Cost-Effectiveness of Extended Adjuvant Rituximab for US Patients Aged 65\u201370 Years with Follicular Lymphoma in Second Remission"],"prefix":"10.3816","volume":"8","author":[{"given":"John W.","family":"Hayslip","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kit N.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.3816\/CLM.2008.n.020_bib1","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1093\/jnci\/92.15.1240","article-title":"Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995","volume":"92","author":"Groves","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.3816\/CLM.2008.n.020_bib2","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1200\/JCO.2005.04.503","article-title":"Improved survival of follicular lymphoma patients in the United States","volume":"23","author":"Swenson","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2008.n.020_bib3","doi-asserted-by":"crossref","first-page":"258","DOI":"10.6004\/jnccn.2006.0025","article-title":"Non-Hodgkin's lymphoma. Clinical practice guidelines in oncology","volume":"4","author":"Zelenetz","year":"2006","journal-title":"J Natl Compr Canc Netw"},{"key":"10.3816\/CLM.2008.n.020_bib4","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1182\/blood-2006-05-021113","article-title":"Rituximab maintenance improves clinical outcome of relapsed\/resistant follicular non-Hodgkin lymphoma in patients both with and without rituximab during induction: results of a prospective randomized phase 3 intergroup trial","volume":"108","author":"van Oers","year":"2006","journal-title":"Blood"},{"key":"10.3816\/CLM.2008.n.020_bib5","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood-2005-06-2508","article-title":"Lymphoma incidence patterns by WHO subtype in the United States, 1992\u20132001","volume":"107","author":"Morton","year":"2006","journal-title":"Blood"},{"key":"10.3816\/CLM.2008.n.020_bib6","first-page":"1","article-title":"United States Life Tables, 2003","volume":"54","author":"Arias","year":"2006","journal-title":"Natl Vital Stat Rep"},{"key":"10.3816\/CLM.2008.n.020_bib7","doi-asserted-by":"crossref","first-page":"7565","DOI":"10.1200\/JCO.2004.00.9217","article-title":"Tositumomab and iodine-131 tositumomab produces durable complete remissions in a subset of heavily pretreated patients with low-grade and transformed non-Hodgkin's lymphomas","volume":"23","author":"Fisher","year":"2005","journal-title":"J Clin Oncol"},{"issue":"suppl 4","key":"10.3816\/CLM.2008.n.020_bib8","doi-asserted-by":"crossref","first-page":"iv25","DOI":"10.1093\/annonc\/mdj995","article-title":"Outpatient fractionated ifosfamide, carboplatin and etoposide as salvage therapy in relapsed and refractory non-Hodgkin's and Hodgkin's lymphoma","volume":"17","author":"Hertzberg","year":"2006","journal-title":"Ann Oncol"},{"key":"10.3816\/CLM.2008.n.020_bib9","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1023\/A:1008399623564","article-title":"High-dose therapy with autologous stem-cell transplantation (ASCT) after first progression prolonged survival of follicular lymphoma patients included in the prospective GELF 86 protocol","volume":"11","author":"Brice","year":"2000","journal-title":"Ann Oncol"},{"key":"10.3816\/CLM.2008.n.020_bib10","first-page":"1422","article-title":"Cost analysis of common treatment options for indolent follicular non-Hodgkin's lymphoma","volume":"90","author":"van Agthoven","year":"2005","journal-title":"Haematologica"},{"key":"10.3816\/CLM.2008.n.020_bib11","first-page":"430a","article-title":"Quality of life (QOL) in elderly patients with aggressive non-hodgkin's lymphoma (NHL) treated with CHOP","volume":"98","author":"Doorduyn","year":"2001","journal-title":"Blood"},{"key":"10.3816\/CLM.2008.n.020_bib12","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1600-0609.2005.00438.x","article-title":"Self-reported quality of life in elderly patients with aggressive non-Hodgkin's lymphoma treated with CHOP chemotherapy","volume":"75","author":"Doorduijn","year":"2005","journal-title":"Eur J Haematol"},{"key":"10.3816\/CLM.2008.n.020_bib13","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.ejca.2004.01.019","volume":"40","author":"van Agthoven","year":"2004","journal-title":"Eur J Cancer"},{"key":"10.3816\/CLM.2008.n.020_bib14","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1080\/10428190600573325","article-title":"Medical costs associated with non-Hodgkin's lymphoma in the United States during the first two years of treatment","volume":"47","author":"Kutikova","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"10.3816\/CLM.2008.n.020_bib15","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1089\/15258160050196812","article-title":"Mobilization, collection, and processing of autologous peripheral blood stem cells: development of a clinical process with associated costs","volume":"9","author":"Meehan","year":"2000","journal-title":"J Hematother Stem Cell Res"},{"key":"10.3816\/CLM.2008.n.020_bib16","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1200\/JCO.2000.18.1.64","article-title":"Predicting costs of stem-cell transplantation","volume":"18","author":"Lee","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2008.n.020_bib17","series-title":"Medical Fees in the United States 2004","year":"2004"},{"issue":"suppl 1","key":"10.3816\/CLM.2008.n.020_bib18","first-page":"58","article-title":"Idiopathic thrombocytopenia purpura: treatment patterns and an analysis of cost associated with intravenous immunoglobulin and anti-D therapy","volume":"35","author":"Simpson","year":"1998","journal-title":"Semin Hematol"},{"key":"10.3816\/CLM.2008.n.020_bib19","first-page":"1545","article-title":"Oncology Nursing Society Workforce Survey. Part I: perceptions of the nursing workforce environment and adequacy of nurse staffing in outpatient and inpatient oncology settings","volume":"28","author":"Lamkin","year":"2001","journal-title":"Oncol Nurs Forum"},{"key":"10.3816\/CLM.2008.n.020_bib20","doi-asserted-by":"crossref","first-page":"197","DOI":"10.6004\/jnccn.2006.0020","article-title":"Documentation of chemotherapy infusion preparation costs in academic-and community-based oncology practices","volume":"4","author":"Brixner","year":"2006","journal-title":"J Natl Compr Canc Netw"},{"key":"10.3816\/CLM.2008.n.020_bib21","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1182\/blood-2006-04-016725","volume":"108","author":"Forstpointner","year":"2006","journal-title":"Blood"},{"key":"10.3816\/CLM.2008.n.020_bib22","doi-asserted-by":"crossref","first-page":"106a","DOI":"10.1182\/blood.V106.11.349.349","article-title":"Maintenance rituximab after CVP results in superior clinical outcome in advanced follicular lymphoma (FL): results of the E1496 phase III trial from the Eastern Cooperative Oncology Group and the Cancer and Leukemia Group B","volume":"106","author":"Hochster","year":"2005","journal-title":"Blood"}],"container-title":["Clinical Lymphoma and Myeloma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155791901170227X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155791901170227X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T06:10:10Z","timestamp":1588918210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S155791901170227X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S155791901170227X"],"URL":"https:\/\/doi.org\/10.3816\/clm.2008.n.020","relation":{},"ISSN":["1557-9190"],"issn-type":[{"value":"1557-9190","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}